Tuberculin skin test conversion in patients under treatment with anti-tumor necrotizing factor alpha agents

Abstract Background Despite successful clinical outcomes of biologic medications in patients with chronic rheumatic diseases, some considerable adverse effects such as infections remain a major concern. Possibility of tuberculosis (TB) reactivation over treatment with anti-tumor necrotizing factor (...

Full description

Bibliographic Details
Main Authors: Mohammad-Esmaeil Hejazi, Atefeh Ahmadzadeh, Alireza Khabbazi, Aliasghar Ebrahimi, Maryam Farmani, Yasin Hejazi
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-020-05166-5